StockDriftsStockDriftsTop 5 Interwest Venture Management Co Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PMVP | PMV PHARMACEUTICALS INC | 48.05% | 1.61M | $9.9M | +0.00%(+0) | — | 2023-09-30 | |
| REAL | THE REALREAL | 24.07% | 2.35M | $5.0M | +0.00%(+0) | — | 2023-09-30 | |
| SERA | SERA PROGNOSTICS | 21.78% | 2.42M | $4.5M | +0.00%(+0) | — | 2023-09-30 | |
| GKOS | GLAUKOS CORP | 5.96% | 16.3K | $1.2M | +0.00%(+0) | — | 2023-09-30 | |
| DARE | DARE BIOSCIENCE INC | 0.14% | 62.1K | $29K | +0.00%(+0) | — | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Interwest Venture Management Co reports $20.64M in US-listed equity holdings across 5 positions in its most recent 13F filing. Its largest disclosed positions are PMVP (48.0%), REAL (24.1%) and SERA (21.8%). Figures reflect the Q3 2023 filing.
Sign up free to track Interwest Venture Management Co, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Interwest Venture Management Co’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1697720). View Interwest Venture Management Co’s 13F filings on SEC